TP53 and neoplasm: Pan‐cancer multi‐omics analysis revealed significant correlations between TP53 mutation status, intratumoral microbiome diversity (particularly in HCC and EC) and altered tumour microenvironment (TME) components, such as reduced endothelial cell abundance.